Takeshi Nishimura

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012

Kenichi Nishioji, Yoshio Sumida, Mai Kamaguchi et al. · Journal of Gastroenterology · 2014 · 159 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met

Kengo Tomita, Toshifumi Azuma, Naoto Kitamura et al. · Gastroenterology · 2004 · 140 citations · Full text

Alcohol-induced Fatty Liver, Metabolic Syndrome, Hepatology +12

Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice

Kanji Yamaguchi, Yoshito Itoh, Chihiro Yokomizo et al. · Laboratory Investigation · 2010 · 123 citations · Full text

The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals

Kenichi Nishioji, Naomi Mochizuki, Masao Kobayashi et al. · PLoS ONE · 2015 · 84 citations · Full text

Metabolic Disorder, Cardiometabolic Risk, Genetic Epidemiology +25

High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells

Chihiro Yokomizo, Kanji Yamaguchi, Yoshito Itoh et al. · Cancer Letters · 2011 · 80 citations

Hcc Predicts, Oncology, Medicine +9